Mercilon (Desogestrel, Ethinylestradiol)

Mercilon, a combined oral contraceptive, acts on the hormonal regulation of the menstrual cycle to prevent pregnancy.

• Contraception: prevention of pregnancy in women of childbearing age
• Menstrual cycle regulation: reduction of irregular bleeding and stabilization of cycle length
• Acne management: improvement of acne lesions associated with hormonal fluctuations

• Desogestrel is a progestogenic agent that suppresses the mid‑cycle surge of luteinizing hormone, thereby inhibiting ovulation. Ethinylestradiol provides estrogenic activity that stabilizes the endometrial lining and enhances negative feedback on gonadotropins, further preventing follicular development. Together, the combination also thickens cervical mucus, creating a barrier to sperm penetration and reducing the likelihood of implantation.

Mercilon may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild stomach upset often occurring at treatment initiation
• Headache: transient tension‑type headaches
• Breast tenderness: temporary swelling or discomfort
• Weight gain: slight increase in body weight
• Mood changes: mild irritability or emotional fluctuations
• Spotting: irregular uterine bleeding, especially during the first cycles

Serious or Rare Side Effects

• Venous thromboembolism: blood clots in deep veins or lungs
• Pulmonary embolism: blockage of pulmonary arteries
• Stroke: cerebrovascular accident
• Myocardial infarction: heart attack
• Severe hypertension: sudden high blood pressure
• Allergic reaction: rash, swelling, or anaphylaxis

Before prescribing Mercilon, healthcare professionals should consider several precautionary measures to ensure patient safety.

• Smoking status: avoid use in women over 35 who smoke due to increased cardiovascular risk
• Cardiovascular history: assess for hypertension, thromboembolic disorders, or coronary artery disease
• Liver function: evaluate hepatic impairment as it may affect hormone metabolism
• Medication history: review concurrent use of enzyme‑inducing drugs that may reduce efficacy
• Pregnancy and lactation: contraindicated during pregnancy; advise breastfeeding women of potential risks
• Store at ambient temperature: keep tablets below 25 °C in the original packaging, protected from moisture and light

Mercilon can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid)

• Antiepileptics (e.g., carbamazepine, phenytoin): significantly reduce hormone levels, compromising contraceptive efficacy
• Rifampicin and other strong enzyme inducers: decrease plasma concentrations of both hormones
• Certain HIV protease inhibitors: may increase hormone levels, raising risk of side effects
• St. John’s wort: herbal inducer that lowers contraceptive effectiveness
• Anticoagulants (e.g., warfarin): estrogen component may enhance anticoagulant effect, requiring monitoring

Moderate Interactions (Monitor Closely)

• Antibiotics (e.g., tetracycline, metronidazole): may have modest impact on hormone levels
• Antifungal agents (e.g., fluconazole): can increase estrogen exposure
• Antidepressants (SSRIs): potential for altered hormone metabolism
• Diuretics (e.g., thiazides): may affect fluid balance and blood pressure
• Herbal supplements (e.g., ginseng): possible interaction affecting efficacy